Behavior During Experimentally Induced Pain
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01594528|
Recruitment Status : Completed
First Posted : May 9, 2012
Last Update Posted : May 14, 2014
|Condition or disease||Intervention/treatment||Phase|
|Schizophrenia Major Depression||Other: pain tests||Not Applicable|
The objective is to search for behavioral non verbal indicators of pain during experimentally induced pain (pressure application, ischemia induction).
Included subjects are subjected to experimental pain tests : pressure application (160 kPa) with an algometer to determine the pain with Visual Analogic Scale (VAS), and ischemia induction to determine the time needed to feel pain with an intensity equivalent to 3 with the VAS.
Subjects are filmed during experimentation to identify the corporal mobility signs, facial expression signs and sonorous signs associated to pain stimulation.
Neurophysiological measures complete these observations : surface electromyogram, heart rate measure, blood pressure.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||15 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Behavior During Experimentally Induced Pain|
|Study Start Date :||April 2012|
|Actual Primary Completion Date :||December 2013|
|Actual Study Completion Date :||December 2013|
No Intervention: diagnosis
diagnosis according to the DSM-IV-TR : major depression and schizophrenia, or control.
Other: pain tests
pain induction with pressure application or ischemia on the arm
- Frequency of behavioral signs [ Time Frame: during pain tests (average 1 hour) ]number of corporal mobility, facial expression and sound indicators
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01594528
|Centre Hospitalier Esquirol|
|Limoges, France, 87025|
|Principal Investigator:||Dominique Malauzat, MD||Centre Hospitalier Esquirol|